United States

Back to map

Showing 61-70 of 345 grants

Title Institution Researcher Program Duration Total Award Amount
Evaluating the Impact of High-Risk HLA-DR Serotypes on the Cellular Neighborhood of the Pancreatic Islets: Towards Early Identification of T1D Disease Risk and Prevention Missouri University of Science and Technology Gina Yosten Cures 01-October-2025 to 30-September-2028 $740.097,60
Combination therapy with STX4 activating small molecules or small activating RNA together with harmine to stimulate beta-cell regeneration and enhance functional beta-cell mass Beckman Research Institute of the City of Hope Debbie Thurmond Cures 01-October-2025 to 30-September-2028 $1.050.000,00
Dual Beta-cell Regenerative and Immunomodulatory Endogenous Agonist as a Replacement Therapy for Type 1 Diabetes Rector & Visitors of the University of Virginia Gordon Laurie Cures 01-October-2025 to 30-September-2027 $300.000,00
Understanding common tissue tolerance mechanisms in autoimmunity Massachusetts General Hospital Gary Reynolds Cures 01-September-2025 to 31-August-2026 $150.000,00
Safety and efficacy assessment of Tegoprubart and calcineurin inhibitors- free immunosuppression therapy for pancreatic islet transplantation in patients with t1DM and chronic kidney disease. The University of Chicago Piotr Witkowski Cures 01-September-2025 to 31-August-2029 $8.500.000,00
microRNAs as regulators of stem cell differentiation into islet cells University of Washington Vincenzino Cirulli Cures 01-August-2025 to 31-July-2027 $600.000,00
Mechanisms of B Cell Polyreactivity in Autoimmunity: Toward Precision Immunotherapy Regents of the University of Colorado Mia Smith Cures 01-September-2025 to 31-August-2026 $149.965,60
Broad Scope CMC, Non-Clinical, and Regulatory Support Dark Horse Consulting Nathan Manley Cures 01-September-2025 to 31-December-2026 $85.000,00
Demand for Combined CGM-Pump Devices in Type 1 Diabetes Magnolia Innovation, LLC Kenneth Howie Improving Lives 01-August-2025 to 06-March-2026 $291.000,00
Towards an integrated proteomic and transcriptomic single-cell atlas of the human pancreas University of Miami Dirk Homann Cures 01-April-2025 to 31-March-2027 $53.972,92